Delivery Order SPE2DB20D3505-SPE2DB24FU6B4

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FU6B4
    Delivery Order

This federal contract award, valued at $13,254.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. The award covers the delivery of 4565135570 CONCERTA ER 27 MG TABLET 100S, a prescription medication, to be completed by July 15, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this contract, which supports the DLA's role in supplying medical products to federal government agencies, particularly military and veterans' healthcare systems.

Generated 2/27/25, 10:38 AM